InvestorsHub Logo
Followers 33
Posts 3008
Boards Moderated 0
Alias Born 07/29/2015

Re: None

Friday, 11/13/2020 5:09:21 PM

Friday, November 13, 2020 5:09:21 PM

Post# of 2720
FDA ANYTIME NOW!!! IMO

From AH news today

support research and development and regulatory activities in support of our anticipated FDA 510(k) submissions for the Acuitas AMR Gene Panel test; (2) commercialize our products, with a focus on the Unyvero platform and diagnostic tests, and the Acuitas AMR Gene Panel test for isolates; (3) support further development and commercialization of the Ares Genetics database and Acuitas Lighthouse Software; (4) fund directed sales and marketing efforts to the customers and collaborators relating to our products and services; (5) invest in manufacturing and operations infrastructure to support sales of products; and (6) the balance, if any, for general corporate purposes. See “Use of Proceeds” on page S-5 of this prospectus supplement



$OPGN

Honesty is the best policy

DD Support Board and Fraud Research Team

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPGN News